Director, System Diabetes Program and Director, Transplant Endocrinology
Houston Methodist
Houston, Texas, United States
Archana R. Sadhu, MD, FACE is Director of Systems Diabetes Program, Houston Methodist, Director of Transplant Endocrinology, Houston Methodist Hospital and holds faculty appointments as Assistant Professor of Medicine at Weill Cornell Medical College and Texas A&M Health Sciences Center.
Dr. Sadhu completed her undergraduate studies with a Bachelor of Science in physiological science, summa cum laude, at the University of California Los Angeles (UCLA). She obtained her medical degree at the David Geffen School of Medicine at UCLA, with the honors, and completed her internship and residency training in Internal Medicine followed by fellowship training in Endocrinology, Diabetes, and Hypertension at UCLA.
Since 2010, Dr. Sadhu has been on the faculty at Houston Methodist in the Division of Endocrinology, Diabetes and Metabolism. Her career focus is to improve outcomes of all patients with diabetes and related metabolic conditions by using evidence based clinical protocols to deliver high quality, comprehensive and cost efficient care. Additionally, Dr. Sadhu has unique expertise in diabetes and endocrinology of a complex group of patients who undergo organ transplantation and in particular, pancreas transplantation. She also performs clinical research to better understand the mechanisms and reduce complications in patients with diabetes and endocrine diseases. Dr. Sadhu has numerous publications in well reputed journals and is an invited lecturer at national and international scientific meetings in her area of expertise.
Disclosure information not submitted.
Diabetes Technology Skills Workshop with Dinner (Separate Ticketed Event)
Wednesday, May 8, 2024
5:15 PM – 9:30 PM CDT
First Time Attendee Orientation
Thursday, May 9, 2024
8:00 AM – 8:45 AM CDT
Keynote: The Art & Science of Empathy and Artificial Intelligence (AI) Accountability
Thursday, May 9, 2024
3:00 PM – 4:30 PM CDT
New Horizons in Diabetes Technology: The Bionic Pancreas
Friday, May 10, 2024
8:00 AM – 8:45 AM CDT
Newest Incretin Options for Diabetes and Obesity
Saturday, May 11, 2024
2:30 PM – 3:30 PM CDT